Discovery of a potent allosteric kinase modulator by combining computational and synthetic methods
PhD student Edwin Kroon from the group Drug Design (Groningen Research Institute of Pharmacy) has discovered an allosteric and potent PDK1 modifier using a combined computational and synthetic approach.
PDK1 is an important kinase target with implications in cancer and diabetes. While pharmaceutical industry is mostly building on ATP competitive inhibitors, the Domling group investigates allosteric binding modes which promise to be more selective and devoid of side effects often seen in kinase drugs. The 3D structural elucidation of the small molecule inhibitor in PDK1 will form the starting point for new potent and selective anti cancer treatments.
The work is a collaboration between the Biondi biochemistry and crystallography group at the Universitatshospital Frankfurt and Camacho from the University of Pittsburgh and has been published in the high profile journal Angewandte Chemie: http://onlinelibrary.wiley.com/doi/10.1002/anie.201506310/abstract
Last modified: | 07 April 2016 11.39 a.m. |
More news
-
02 July 2025
Relinde Weil reappointed as a member of the Supervisory Board UG
The Minister of Education has reappointed Relinde Weil for a second term as a member of the Supervisory Board of the University of Groningen.
-
01 July 2025
Khalaf Alkhalaf elected Alumnus of the Year 2025
Khalaf Alkhalaf has been elected Alumnus of the Year 2025 by the University of Groningen. He has received the award for his commitment to providing good care and guidance to refugees in the Netherlands and the inspiring way in which he shares his...